Comparison of Bevacizumab and Aflibercept for Suppression of Angiogenesis in Human Retinal Microvascular Endothelial Cells

Yazdanyar, A; Cai, CL; Aranda, JV; Shrier, E; Beharry, KD

Beharry, KD (通讯作者),State Univ New York, Downstate Hlth Sci Univ, Dept Ophthalmol, Brooklyn, NY 11203 USA.;Beharry, KD (通讯作者),State Univ New York, Downstate Hlth Sci Univ, Dept Pediat, Div Neonatal Perinatal Med, Brooklyn, NY 11203 USA.

PHARMACEUTICALS, 2023; 16 (7):

Abstract

Bevacizumab (Avastin) is a vascular endothelial growth factor (VEGF) inhibitor that is widely used for aggressive posterior retinopathy of prematurity......

Full Text Link